about
Purification of cardiomyocytes from differentiating pluripotent stem cells using molecular beacons that target cardiomyocyte-specific mRNACell therapy with embryonic stem cell-derived cardiomyocytes encapsulated in injectable nanomatrix gel enhances cell engraftment and promotes cardiac repair.Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.The modulation of cardiac progenitor cell function by hydrogel-dependent Notch1 activation.Molecular beacon-enabled purification of living cells by targeting cell type-specific mRNAs.Non-genetic Purification of Ventricular Cardiomyocytes from Differentiating Embryonic Stem Cells through Molecular Beacons Targeting IRX-4.Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cellsPeptide-mediated disruption of calmodulin-cyclin E interactions inhibits proliferation of vascular smooth muscle cells and neointima formation.Cardiovascular Regeneration: Biology and Therapy.Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.Phosphatidylinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning.Cardiac-specific inducible overexpression of human plasma membrane Ca2+ ATPase 4b is cardioprotective and improves survival in mice following ischemic injury.In vivo transduction of ETV2 improves cardiac function and induces vascular regeneration following myocardial infarctionMaturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells: Current Strategies and LimitationsRegulation of the Intracellular ROS Level Is Critical for the Antiproliferative Effect of Quercetin in the Hepatocellular Carcinoma Cell Line HepG2In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repairDual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarctionAuthor Correction: In vivo transduction of ETV2 improves cardiac function and induces vascular regeneration following myocardial infarctionNanovesicles derived from iron oxide nanoparticles-incorporated mesenchymal stem cells for cardiac repair
P50
Q30561343-6000B523-A35F-416E-A701-0E4767EA9257Q30596468-3D85A082-C2BF-4A99-9D7B-8EC69303DBC1Q33821060-EA81D358-E36E-420D-AA62-E77BCC803FFEQ34115085-36011E3F-FAA6-4437-91C6-E74E45343F5BQ35077743-1BFE1ED6-1617-4F1A-A4AB-B268322D91F4Q36379875-C641585D-52E7-4650-BFF4-1B5A2B271DE5Q36565384-46A45B39-ACDD-4C47-8468-9917A54933F7Q38464705-6C99EE58-BBB9-4A3C-8829-1C31FEB6B137Q42359737-2A8E5230-8D9D-48D7-AA6E-1B46C8FC9E49Q43155141-55E1BA0B-19FA-4F38-A29C-5FD43A0EA353Q46440002-852C5F5A-D0D4-4274-9F64-CC706AAAC60EQ52682477-EF50E367-B72B-47EE-BC80-2344B5ABFB2CQ64238652-11016EDF-A129-41CB-9992-510D99FE5B9EQ89066269-7E494F17-55A6-4B58-9999-A29322DCA15DQ91127817-86CB6696-8A7E-4CA1-9EBA-1C95D86DA8D1Q91878243-3176D48D-5C72-421D-BB9E-F7C8B575AC3DQ91936572-91FD2CA7-9C63-476E-BABF-F329452958B8Q93106184-6381EE43-4033-4B7E-8A46-496DD9A61B0FQ96136503-1652EE2B-97DE-4285-9AEE-18710F566337
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kiwon Ban
@ast
Kiwon Ban
@en
Kiwon Ban
@es
Kiwon Ban
@nl
type
label
Kiwon Ban
@ast
Kiwon Ban
@en
Kiwon Ban
@es
Kiwon Ban
@nl
prefLabel
Kiwon Ban
@ast
Kiwon Ban
@en
Kiwon Ban
@es
Kiwon Ban
@nl
P106
P1153
24174155600
P31
P496
0000-0003-0805-5439